{
    "Trade/Device Name(s)": [
        "VITEK\u00ae 2 AST-Gram Negative Eravacycline",
        "VITEK\u00ae 2 AST-GN Eravacycline"
    ],
    "Submitter Information": "bioM\u00e9rieux, Inc.",
    "510(k) Number": "K191766",
    "Predicate Device Reference 510(k) Number(s)": [
        "K183524"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "LON",
        "LTW",
        "LTT"
    ],
    "Summary Letter Date": "June 28, 2019",
    "Summary Letter Received Date": "July 1, 2019",
    "Submission Date": "June 28, 2019",
    "Regulation Number(s)": [
        "21 CFR 866.1645"
    ],
    "Regulation Name(s)": [
        "Fully Automated Short-Term Incubation Cycle Antimicrobial Susceptibility System"
    ],
    "Analyte Class(es)": [
        "microbiology"
    ],
    "Analyte(s)": [
        "Eravacycline"
    ],
    "Specimen Type(s)": [
        "Gram negative bacilli isolates"
    ],
    "Specimen Container(s)": [
        "Saline suspension"
    ],
    "Instrument(s)/Platform(s)": [
        "VITEK\u00ae 2",
        "VITEK\u00ae 2 Compact"
    ],
    "Method(s)/Technology(ies)": [
        "Automated quantitative antimicrobial susceptibility test",
        "Microdilution minimum inhibitory concentration (MIC)"
    ],
    "Methodologies": [
        "Growth pattern analysis",
        "Broth microdilution",
        "MIC determination"
    ],
    "Submission Type(s)": [
        "Reagent",
        "Card",
        "System",
        "Analyzer"
    ],
    "Document Summary": "FDA 510(k) summary for VITEK 2 AST-Gram Negative Eravacycline antimicrobial susceptibility card for automated MIC testing of Gram negative bacilli",
    "Indications for Use Summary": "Intended for antimicrobial susceptibility testing of Gram negative bacilli using VITEK 2 systems in clinical laboratories; Eravacycline activity assessed for specific Gram negative bacteria as a quantitative test",
    "fda_folder": "Microbiology"
}